BCL7A

gene product
BCL7
This gene is directly involved, with Myc and IgH, in a three-way gene translocation in a Burkitt lymphoma cell line. As a result of the gene translocation, the N-terminal region of the gene product is disrupted, which is thought to be related to the pathogenesis of a subset of high-grade B cell non-Hodgkin lymphoma. The N-terminal segment involved in the translocation includes the region that shares a strong sequence similarity with those of BCL7B and BCL7C. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
More gene data

Featured antibodies

Antibodies

 

Filters

Application

Antibodypedia Validation Initiative

Validation method

Reference

Provider

Host

Reactivity

Antibody type

Conjugate

Antibody

  or   Clear
Enhanced validation
Enhanced validation
Supportive data in Antibodypedia
Data presented on provider website
Data in Antibodypedia (inconclusive)
Validated within AVI
Eligible for validation within AVI
195 antibodies from 32 providers.

Antibody properties

General

Applications

or Cancel
Antibody
Novus Biologicals
3 antibodies
GeneTex
3 antibodies
Atlas Antibodies
1 antibody
Invitrogen Antibodies
6 antibodies
antibodies-online
60 antibodies
Affinity Biosciences
1 antibody
Abnova Corporation
5 antibodies
LifeSpan BioSciences, Inc.
28 antibodies
Antibodies.com
1 antibody
Cusabio Biotech Co., Ltd
1 antibody
Aviva Systems Biology
6 antibodies
Biorbyt
6 antibodies
Everest Biotech
1 antibody
NSJ Bioreagents
1 antibody
OriGene
5 antibodies
Acris Antibodies GmbH
4 antibodies
Abgent
2 antibodies
Arigo
1 antibody
Bioworld Technology, Inc
1 antibody
RabMAbs
1 antibody
MyBioSource
4 antibodies
St John's Laboratory
2 antibodies
Boster Biological Technology
1 antibody
Cell Signaling Technology, Inc
1 antibody
ProSci
1 antibody
Abbexa
2 antibodies
Creative Diagnostics
2 antibodies
Abbkine Scientific Co.Ltd.
1 antibody
EMD Millipore
1 antibody
United States Biological
39 antibodies
Leading Biology
1 antibody
MilliporeSigma / Merck KGaA
3 antibodies